Halt All Lethal Trafficking of Fentanyl Act

Floor Speech

BREAK IN TRANSCRIPT

Mr. MILLS. Mr. Chair, today I stand before you to emphasize the critical need for the Department of Defense's involvement in fentanyl research.

My amendment would include the Department of Defense in the list of eligible agencies that qualify for the expedited procedures on fentanyl research.

The Department of Defense has several existing research programs involving fentanyl, and considering that today's servicemembers are tomorrow's veterans, there is no reason why the DOD should be ineligible for these expedited processes.

Not only should this bill be directed at our veterans but the brave men and women who serve on Active Duty and are also susceptible to injuries that are routinely prescribed opioids as the treatment. As we all know, this can lead to serious addictions.

My amendment would ensure that the DOD is included in the research and reporting process of fentanyl and its effects.

As someone who was blown up twice overseas and was a combat medic, I know firsthand the pain and the injuries that the brave men and women in uniform can sustain.

Common combat injuries can include second and third degree burns, spinal cord injuries, broken bones, limb loss, paralysis, and sharpened wounds.

As we face this ever-growing crisis, it is imperative that our military actively participate in fentanyl research for several compelling reasons.

By actively participating in fentanyl research, the DOD can make significant strides in addressing the opioid crisis within the ranks and improving the quality of healthcare provided through TRICARE to our brave servicemembers.

Allow me to share some of these alarming statistics concerning the use of opioids among our Active Duty personnel.

According to a study conducted by the Defense Health Agency, between the years of 2012 and 2017, the rate of opioid prescriptions within the military healthcare system has increased by a staggering 56 percent.

This trend is deeply concerning as it highlights the potential risks and challenges faced by our servicemembers when it comes to opioid misuse and addiction.

It is crucial to recognize that the DOD has a responsibility to ensure the physical and mental well-being of our military personnel.

Engaging in fundamental research will allow the DOD to gain a deeper understanding of the specific challenges faced by Active Duty servicemembers regarding opioid usage.

By providing the necessary support and resources to combat opioid addiction, the Department of Defense can empower our servicemembers to overcome this critical challenge and continue to fulfill their duties with resilience and strength.

This research can lead to the development of new and innovative therapies, improved access to treatment resources, and more comprehensive addiction prevention programs for servicemembers abroad.

It is essential to note that by prioritizing fentanyl research, the Department of Defense demonstrates its commitment to the overall well- being of our Active Duty personnel.

By addressing the fentanyl and opioid crisis proactively, they will not only protect the lives and health of our servicemembers but also foster a culture of support and understanding within our military communities.

This, in turn, contributes to the overall readiness and effectiveness of our Armed Forces, and I strongly urge my colleagues to support this amendment.

Mr. Chair, I yield to the gentleman from Indiana.

BREAK IN TRANSCRIPT

Mr. MILLS. Mr. Chair, I yield back the balance of my time.

BREAK IN TRANSCRIPT

Source